|

RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

RECRUITINGSponsored by The Radiosurgery Society
Actively Recruiting
SponsorThe Radiosurgery Society
Started2012-03
Est. completion2030-12
Eligibility
Healthy vol.Accepted
Locations13 sites

Summary

The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients with life threatening tumors and other diseases. (This study was formally called ReCKord and included the CyberKnife only; The ReCKord study continues as a CyberKnife subset of RSSearch.)

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy
* Willingness to sign an Informed Consent Document or verbally agree to participation

Exclusion Criteria:

* There are no specific exclusion criteria, but patients who are unwilling to sign the ICD or who decline participation will not be included

Conditions7

Arteriovenous Malformation of Central Nervous SystemCancerLiver CancerLiver DiseaseLung CancerNeoplasmsTrigeminal Neuralgia

Locations13 sites

Penrose Cancer Center
Colorado Springs, Colorado, 80907
Sylvester Comprehensive Cancer Center, University of Miami
Miami, Florida, 33146
Gregory A Azzam, MDgxa338@med.miami.edu
Southeast Georgia Health System
Brunswick, Georgia, 31520
Henry Ford Health System
Detroit, Michigan, 48202
Celina Kirsch, P.A.313-640-2345CKirsch2@hfhs.org
AtlantiCare Regional Medical Center and AtlantiCare Cancer Care Institute
Egg Harbor, New Jersey, 08234

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.